First-Line PTSD Treatment: Trauma-Focused Psychotherapy Versus Medication When Access Isn't Equal
VA/DoD and ISTSS guidelines favor trauma-focused psychotherapy over medication as first-line treatment for PTSD. Two patients, one with a trained therapist available and one without, show why prescribing so often runs the other way anyway.
N.S. is a 29-year-old man, a former Marine now working as a firefighter paramedic in a mid-sized city, who developed PTSD following a mass-casualty response he was first on scene for two years ago. He lives with his girlfriend and continues working full shifts, though he has started avoiding his old running route because it passes near the site. He is otherwise healthy, with no psychiatric or medical history, and has never taken a psychiatric medication.
He is being seen at a VA-affiliated outpatient clinic that has, unusually for the region, a full roster of therapists trained in both cognitive processing therapy and prolonged exposure, with a realistic intake wait of about three weeks. VA/DoD guidelines list trauma-focused psychotherapy above medication as first-line treatment, based on larger effect sizes in head-to-head and network meta-analyses; that recommendation is not a theoretical preference here — it is genuinely available to him within a timeframe that matters. The question this visit actually has to answer is not whether psychotherapy is superior in principle, which nobody in the room disputes, but whether starting medication now, while he waits those three weeks, adds anything worth the cost of another variable in his treatment course, or whether it would be better to simply hold and let the therapy itself be the first-line treatment the guideline says it should be.
At the intake visit
The guideline preference exists for exactly this patient. He has real access to CPT or PE within a genuinely short wait, he is functioning well enough to engage with it, and starting an SSRI now adds a variable that could muddy whether it was the therapy or the medication doing the work, without any guideline basis for needing both from day one.
Three weeks of continued avoidance and disrupted sleep is not nothing for someone doing a physically and emotionally demanding job. I would not talk him out of starting sertraline now if he wants it — it does not preclude starting therapy on schedule, and for a patient this functional, a medication bridge while he waits is a reasonable use of the guideline's flexibility, not a violation of it.
Given that he has real, near-term access to first-line psychotherapy, I would let him decide this one rather than default either way — explain that medication is not required to get the same benefit the guideline is describing, and that waiting three weeks and starting therapy alone is a completely defensible choice for someone functioning at his level.
N.S. chose to wait for therapy alone rather than start medication in the interim, and intake was confirmed for three weeks out.
The team's agreement was genuine, not just polite consensus: because trauma-focused psychotherapy was actually reachable within a short, real timeframe, medication was offered but never treated as necessary — a distinction from Case B's visit that the team was about to be reminded of directly.
G.P. is a 44-year-old woman who manages a family-owned feed store in a rural county roughly two hours from the nearest city, developed PTSD after surviving a house fire that killed a neighbor attempting to help her escape, and has been managing three children and the store largely on her own since her husband's work keeps him traveling most weeks. She has mild, diet-controlled type 2 diabetes and is otherwise healthy, with no prior psychiatric treatment.
The clinic serving her county has no therapist trained in cognitive processing therapy or prolonged exposure, and the nearest one who is takes new patients only through a waitlist currently running past four months, with no telehealth option her insurance will cover for specialty psychotherapy. The same VA/DoD guideline that put N.S.'s therapy first, with genuine confidence, simply has nothing useful to say to G.P. about how to get the treatment it recommends — the recommendation assumes an infrastructure that does not exist where she lives. Her symptoms are significant: nightly nightmares, intrusive memories triggered by smoke or the smell of her own stove, and a level of hypervigilance that has started affecting her ability to manage the store's early-morning deliveries. She has already called two counseling practices listed on her insurance directory, and both confirmed by phone that neither clinician on staff has any training in trauma-focused modalities, which is part of why she arrives at this visit already fairly sure medication is her only real option.
At the intake visit
Whatever the guideline's stated preference, it was never written to leave a patient in her position untreated for four-plus months while waiting for an appointment that may not even be reachable once it comes. Medication is not a second-best substitute here — for G.P., specifically, it is the only first-line treatment that actually exists.
Agreed without reservation, but I want to name what we are trading away, not pretend the guideline's preference doesn't matter simply because it isn't reachable: the effect sizes for medication alone are real but generally smaller than trauma-focused psychotherapy's, and we should keep actively looking for any telehealth-covered CPT option rather than treating medication as a permanent substitute.
If a covered telehealth option opens up in six months, that changes the plan immediately — this is medication because psychotherapy is currently unreachable, not because it is judged equal to it.
Sertraline, started now, with explicit documentation of why: not a downgrade in care, but the actual first-line option available to this specific patient in this specific place. We should also flag her to social work for any regional telehealth grant programs aimed at exactly this rural-access gap.
Sertraline started at 25 mg with a plan to titrate, and a social work referral placed to search for any covered telehealth trauma-focused psychotherapy options.
Agreed explicitly that this decision reflects access, not a reassessment of which treatment works better in principle — the plan is to revisit trauma-focused psychotherapy the moment it becomes genuinely reachable, not to treat medication as having settled the question.